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ABSTRACT      
 
Objective: We evaluated the effects of calcium pyruvate supplementation during training on body composition and 
metabolic responses to exercise. 
 
Method: Twenty-three untrained females were matched and assigned to ingest in a double blind and randomized 
manner either 5 g of calcium pyruvate (PYR) or a placebo (PL) twice daily for 30 d while participating in a super-
vised exercise program. Prior to and following supplementation, subjects had body composition determined via hy-
drodensiometry; performed a maximal cardiopulmonary exercise test; and performed a 45-min walk test at 70% of 
pre-training VO2 max in which fasting pre- and post exercise blood samples determined. 
 
Results: No significant differences were observed between groups in energy intake or training volume. Univariate 
repeated measures ANOVA revealed that subjects in the PYR group gained less weight (PL 1.2 ± 0.3, PYR 0.3 ± 0.3 
kg, P = 0.04), lost more fat (PL 1.1 ± 0.5; PYR −0.4 ± 0.5 kg, P = 0.03), and tended to lose a greater percentage of 
body fat (PL 1.0 ± 0.7; PYR −0.65 ± 0.6%, P = 0.07), with no differences observed in fat-free mass (PL 0.1 ± 0.5; 
PYR 0.7 ± 0.3 kg, P = 0.29). However, these changes were not significant when body composition data were ana-
lyzed by MANOVA (P = 0.16). There was some evidence that PYR may negate some of the beneficial effects of 
exercise on HDL values. No significant differences were observed between groups in maximal exercise responses or 
metabolic responses to submaximal walking. 
 
Conclusions: Results indicate that PYR supplementation during training does not significantly affect body composi-
tion or exercise performance and may negatively affect some blood lipid levels. 
 
Keywords     Pyruvate, Body composition, Lipids, Ergogenic aid, Exercise 
 
 
 
INTRODUCTION 
Pyruvate is a three-carbon compound that serves 
as the gateway compound between the glycolysis 
pathway and the Krebs cycle. During high-
intensity anaerobic exercise, the pyruvate that is 
formed from the breakdown of sugars and amino 
acids is converted into lactate by lactate dehy-
drogenase. Under aerobic conditions, the py-
ruvate is shuttled into the mitochondria, where it 
is converted in acetyl coenzyme A by the py-
ruvate dehydrogenase complex. Several previous 
studies have indicated that calcium and/or sodi-
um pyruvate supplementation enhances weight 
and fat loss and improves exercise capacity pri-
marily in overweight individuals (1), (2), (3) and 
(4). Hence, pyruvate has recently become a 
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popular weight-loss supplement and proposed 
ergogenic aid. 
However, these claims have been based on a 
small number of studies primarily emanating 
from one laboratory. For example, Stanko et al. 
(1) investigated the effects of pyruvate supple-
mentation on body composition alterations in 
morbidly obese women who were housed in a 
metabolic ward for 21 d. Subjects were restricted 
from performing any exercise while consuming 
hypocaloric diets ranging from 2.1 to 4.25 MJ/d. 
Subjects were fed in a double blind and random-
ized manner with pyruvate or glucose to account 
for 13% or 20% of daily energy intake (∼16 g/d), 
respectively. Results indicated that subjects fed 
pyruvate exhibited greater weight loss and fat 
loss, with no changes in lean body mass. This 
research group also reported that large doses of 
calcium pyruvate (i.e., 22 to 44 g/d for up to 6 
wk) resulted in positive changes in body compo-
sition (5) and (6). Collectively, these findings 
suggest that ingestion of 16 to 44 g/d of calcium 
pyruvate may promote weight loss in overweight 
populations. 
Although these findings support the potential 
use of calcium pyruvate as a weight-loss dietary 
supplement, the practicality and affordability of 
subjects taking large doses of calcium pyruvate 
in an attempt to manage body composition has 
been questioned (7). For this reason, several re-
search groups have evaluated the effects of in-
gesting smaller amounts of calcium pyruvate on 
weight loss. For example, Kalman et al. (7) re-
ported modest but significant decreases in body 
weight and body fat in subjects administered 6 
g/d of calcium pyruvate for 6 wk in comparison 
with placebo. Conversely, Stone et al. (8) report-
ed that pyruvate supplementation (0.22 g · kg−1 · 
d−1 or about 9 g/d for 5 wk) did not significantly 
affect body composition or training adaptations 
in college football players. 
Although several studies have indicated that 
pyruvate supplementation may affect body com-
position, the mechanisms of action are not fully 
understood. One theory proposes that pyruvate 
may influence the manner and efficiency in 
which ingested foods are used, resulting in en-
hanced lipolysis and an increased proportion of 
energy derived from fat (1). In addition, News-
holme (9) proposed that pyruvate may activate a 
futile cycle, such as the pyruvate-
phosphoenolpyruvate cycle, resulting in excess 
energy and fat oxidation. However, more re-
search is needed to understand the effects of cal-
cium pyruvate supplementation on appetite, en-
ergy intake, energy metabolism, and body com-
position before conclusions can be drawn. The 
purpose of this study was to 1) determine wheth-
er calcium pyruvate supplementation affects 
body composition in moderately overweight, un-
trained women who were initiating a standard 
exercise program; 2) evaluate the effects of cal-
cium pyruvate supplementation on metabolic re-
sponses to maximal and sustained exercise; and 3) 
examine the effects of pyruvate supplementation 
on clinical chemistry profiles. 
MATERIALS AND METHODS 
Subjects 
Eighty-seven women responded to advertise-
ments posted in local newspapers and on the 
campus of the University of Memphis (Memphis, 
TN, USA). From this pool, 34 women initially 
enrolled in the study. Subjects were informed 
about the experimental procedures, they com-
pleted medical history and exercise training 
forms, and they signed informed consent state-
ments that adhered to guidelines established by 
the American College of Sports Medicine and the 
institutional review board at the University of 
Memphis. Twenty-three healthy, moderately 
overweight women completed all aspects of the 
study. Subjects were 33 ± 8 y of age, weighed 
71.5 ± 11 kg, had a body mass index of 27.4 ± 3 
kg/m2, and had a maximal oxygen uptake of 34.4 
± 7 mL · kg−1 · min−1. None of the subjects was 
involved in a resistance training program for 3 
mo before the start of this study. Because data 
were collected before and after a 30-d exercise 
and nutrition intervention, no specific effort was 
made to standardize the start of the study to a 
given time of subjects’ menstrual cycles. How-
ever, subjects did not start the study during men-
EFFECTS OF CALCIUM PYRUVATE SUPPLEMENTATION  |  PAULINE KOH-BANERJEE et al 
4!!!!!DIGITALCOMMONS@WSU  |  2005!
struation. Most women involved in this study 
reported taking oral contraceptives. Subjects who 
did not complete the study withdrew or were 
withdrawn primarily due to an inability to com-
ply with the study training protocol and/or per-
sonal issues. 
Experimental design 
Subjects were instructed to maintain their normal 
diets throughout the study and were not allowed 
to ingest any other nutritional supplements (i.e., 
vitamins, minerals, proposed ergogenic aids, etc.). 
Baseline assessments were conducted over a 3-d 
period and involved participating in two testing 
sessions. Before reporting to the laboratory for 
baseline testing, subjects recorded dietary intake 
(food and liquid) for 4 d. Subjects observed a 4-h 
fast before reporting to the laboratory on each 
visit. In the first visit, subjects had body mass 
and body composition determined, and they per-
formed a maximal cardiopulmonary exercise test 
on a treadmill. During the second visit, subjects 
reported to the laboratory after a 4-h fast and do-
nated venous blood samples. Subjects rested for 
30 min and then performed a 45-min walk test on 
a treadmill at a work rate corresponding to 70% 
of maximal oxygen uptake. Venous blood sam-
ples were also obtained immediately after the 
walk test. 
Once baseline tests were conducted, subjects 
were matched and paired based on body mass, 
percentage of body fat, body mass index, age, 
and reported activity levels. In a randomized and 
double-blind fashion, subjects were then as-
signed to a pyruvate group or a placebo group. 
Subjects ingested 5 g of calcium pyruvate (PYR) 
or 5 g of a placebo (PL) that contained 2.5 g of 
calcium carbonate, 4 g of maltodextrin, and 1 g 
of dextrose two times daily (10 g/d) for 30 d. 
Supplements were prepared in powdered form 
with similar taste, texture, and appearance and 
coded in generic packets for double-blind admin-
istration. Subjects were instructed to mix the 
supplement powder into approximately 8 oz of 
fluid and to ingest the solution two times daily. 
Supplement packets were administered in two 
15-d supply allotments. Empty packets were col-
lected from subjects to determine compliance in 
taking the supplements. In addition, subjects 
completed a questionnaire after the study and 
reported a 94% compliance rate in taking the 
supplements. 
Subjects were then prescribed a 30-d pro-
gram of resistance training and walking. Re-
sistance training involved performing two sets of 
8 to 12 repetitions on eight Nautilus machines 
(seated leg press, leg extension, leg curl, bench 
press, shoulder press, lateral pull-down, back ex-
tension, and abdominal curl) three times per 
week. Subjects were instructed to rest approxi-
mately 60 s between each set and to complete 
both sets of each exercise before continuing to 
the next exercise. Once subjects could complete 
12 repetitions of an exercise for both sets, they 
were instructed to progress to the next machine 
weight. Subjects also walked for 30 min at a 
work rate equivalent to 70% of maximal oxygen 
uptake three times per week. Exercise sessions 
were monitored by research assistants and all 
workouts were recorded in training logs. 
Sessions after testing were conducted over a 
3-d period after 30 d of supplementation and 
training. All post-testing sessions were conduct-
ed in a similar manner as testing before supple-
mentation. Therefore, subjects recorded dietary 
intake for the final 4 d of the experimental period, 
had their body compositions determined, per-
formed a maximal cardiopulmonary exercise test, 
and repeated the 45-min walk test over a 3-d pe-
riod. Subjects were instructed to consume the 
same meal and fluids 4 h before each walk test. 
The only difference between testing sessions was 
that subjects ingested their assigned supplement 
mixed in a non-caloric flavored drink 30 min be-
fore donating a pre-exercise blood sample. 
Procedures 
Nutritional records were interpreted and analyzed 
by a registered dietitian using Food Processor III 
nutritional analysis software (Nutritional Sys-
tems, Salem, OR, USA). Body weight was meas-
ured with the subjects dressed in bathing suits 
and standing on a calibrated electronic scale with 
a precision of ±0.02 kg (Sterling Scale Company, 
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Southfield, MI, USA). Body composition was 
determined by standard hydrostatic weighing 
procedures (10) and a spring-loaded autopsy 
scale (Chatillon, New York, NY, USA). Vital 
capacity was assessed before underwater sub-
mersions with a Quinton Q-Plex metabolic cart 
spirometer (Quinton Instruments, Seattle, WA, 
USA). Vital capacity was also obtained with a 
hand-held spirometer (Micro Medical Limited, 
Kent, UK) during each submersion trial to verify 
that subject expired all of their air. Subjects per-
formed 8 to 12 consecutive underwater weighing 
tests until the highest underwater weight could be 
replicated three times. Body composition was 
determined by using the average of the best two 
trials. Residual lung volume was estimated as 28% 
of vital capacity according to standard proce-
dures (10) and (11). Body density and body 
composition were then calculated with Siri’s 
equation (10). 
The maximal cardiopulmonary exercise and 
45-min walk tests were performed on a Quinton 
Q-55 treadmill attached to a Quinton Q-Plex 
metabolic measurement cart (Quinton Instru-
ments). Metabolic analyzers were calibrated to 
certified gases, and the Pneumotach was calibrat-
ed by using a 3-L volume syringe before each 
test according to standard procedures. Bruce’s 
maximal exercise test protocol was used to ob-
tain maximal exercise responses. Subjects re-
ceived verbal encouragement to exercise to the 
best of their ability. The test was terminated once 
the subjects reached volitional exhaustion ac-
cording to standard termination criteria. Ventila-
tory anaerobic thresholds were determined in a 
blind manner according to standardized criteria, 
namely by the point of non-linear increase in 
ventilation, a non-linear increase in carbon diox-
ide production, and an increase in respiratory ex-
change ratio (RER) as work rate incrementally 
increased (12). 
During the 45-min walk test, subjects exer-
cised at a work rate corresponding to 70% of pre-
training maximal oxygen uptake. Breath-by-
breath oxygen uptake, RER, and exercise heart 
rate responses were obtained throughout the walk 
test and averaged at 3-min intervals for statistical 
analysis. In addition, rating of perceived exertion 
was obtained every 5 min during testing. 
Blood samples were obtained from an ante-
cubital forearm vein according to standard phle-
botomy procedures before and after the walk 
tests. Venous blood was collected into two 10-
mL serum separation tubes and a 5-mL K3 anti-
coagulation tube that contained ethylene-
diaminetetra-acetic acid. Serum separation tubes 
were centrifuged at 5000 revolutions/min for 10 
min with a Biofuge 17R centrifuge (Heraeus Inc., 
Mannheim, Germany). Serum was then separated 
from the serum separation tubes, placed in serum 
storage containers, and refrigerated until analysis. 
The tube that contained ethylene-diaminetetra-
acetic acid and one serum vial were shipped 
overnight in cold containers to Quest Diagnostics 
(St. Louis, MO, USA) for clinical analysis. A 
complete clinical chemistry panel (31 items) was 
run on serum samples by using the Technicon 
DAX (model 96-0147, Technicon Inc., Ter-
rytown, NY, USA) automated chemistry analyzer 
according to standard clinical procedures. Cell 
blood counts with percent differentials were run 
on whole blood samples by using a Coulter 
STKS automated analyzer (Coulter Inc., Hialeah, 
FL, USA) according to standard procedures. The 
remaining serum vials were frozen at −80°C until 
the end of the study. Non-esterified fatty acids, 
glycerol, and β-hydroxybutyrate concentrations 
were determined by a Milton-Roy DUV spectro-
photometer (Milton-Roy Company, Rochester, 
NY, USA) using kits for non-esterified fatty ac-
ids (Wako Diagnostic, Richmond, VA, USA) and 
for triacylglycerol GPO-trinder and β-
hydroxybutyrate (Sigma Diagnostic, St. Louis, 
MO, USA). Test-to-test reliability of performing 
these assays ranged from 2% to 6% for individu-
al assays, with an average variation of ±3%. 
Statistical analysis 
Data were analyzed by analysis of variance 
(ANOVA) for repeated measures with least sig-
nificant difference post hoc procedures by using 
SPSS 11.5 for Windows (SPSS Inc., Chicago, IL, 
USA). Interactions between groups were also 
examined by calculating Δ scores (values after 
EFFECTS OF CALCIUM PYRUVATE SUPPLEMENTATION  |  PAULINE KOH-BANERJEE et al 
6!!!!!DIGITALCOMMONS@WSU  |  2005!
versus before supplementation) and analyzing the 
Δ data by one-way ANOVA when only one data 
point was analyzed (e.g., changes in body com-
position data) or by repeated measures ANOVA 
when multiple data points were analyzed (e.g., 
changes in mean oxygen uptake and RER values 
during the walk test). This procedure yields the 
same statistical outcomes as observed in raw data 
analysis and has been used in numerous studies 
to demonstrate changes observed across groups 
in a simple and statistically sound manner. Be-
cause determination of body composition using 
hydrostatic weighing techniques assesses three 
related measurements of body mass, a multivari-
ate ANOVA was run on body composition data 
to assess the overall effect of the supplementa-
tion protocol on body composition variables to 
account for possible experiment-wise error. Data 
were considered statistically significant when the 
probability of type I error was 0.05 or less. Sta-
tistical power and 95% confidence intervals (CIs) 
are also presented on selected variables. Data are 
presented as means ± standard deviations. 
RESULTS 
Training volume 
No significant differences were observed be-
tween groups in total resistance training volume 
(PL 49 579 ± 5186 kg, PYR 54 409 ± 3995 kg, P 
= 0.47) or total exercise time (PL 347 ± 41 min, 
PYR 388 ± 27 min, P = 0.40). 
Dietary variables 
Table 1 presents dietary intake data for the 
PL and PYR groups. No significant differences 
were observed between groups in energy intake, 
fat intake, protein intake, or carbohydrate intake. 
Although not significant, there was some evi-
dence that subjects in the PYR group decreased 
energy intake after supplementation (PL −8.0 ± 3 
kJ · kg−1 · d−1, PYR −21.5 ± 12 kJ · kg−1 · d−1, P = 
0.30). 
 
 
Body composition 
Table 2 presents the body composition data ob-
served between groups, and Fig. 1 presents the 
changes observed in body composition variables 
from baseline values (i.e., Δ values). Univariate 
repeated measures ANOVA showed significant 
group × time interactions in body weight (P = 
0.04) and body fat (P = 0.03). Changes in per-
centage of body fat tended to be different (P = 
0.07), with no differences observed between 
groups in fat-free mass (P = 0.29). Similarly, 
one-way ANOVA performed on body composi-
tion Δ values showed significant differences be-
tween groups in body mass (PL 1.2 ± 0.3 kg, CI 
= −0.39–1.0; PYR 0.3 ± 0.3 kg, CI = 0.7–1.8; P 
= 0.04) and fat mass (PL 1.1 ± 0.5 kg, CI = 0.03–
2.2; PYR −0.4 ± 0.5 kg, CI = −1.4 to 0.6; P = 
0.03), with some evidence that subjects in the 
PYR group lost a greater percentage of body fat 
(PL 1.0 ± 0.7%, CI = 0.45–2.5; PYR −0.65 ± 
0.6%, CI = −1.9 to 0.6; P = 0.07). No significant 
differences were observed in changes in fat-free 
mass (PL 0.1 ± 0.5 kg, CI = −1.0 to 1.2; PYR 0.7 
± 0.3 kg, CI = 0.02–1.4; P = 0.29). However, 
four observations should be noted. First, changes 
in body composition variables were relatively 
minor and well within the typical test-to-test var-
iability (i.e., 5% to 8% using hydrostatic weigh-
ing techniques to assess body composition). Se-
cond, the significant interactions observed in 
body mass and fat mass appeared to have been 
influenced to a greater degree by changes ob-
served in the PL group rather than in the PYR 
group. Third, multivariate ANOVA of related 
body composition variables indicated that there 
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was no overall effect on body composition varia-
bles (P = 0.16). Fourth, univariate body composi-
tion data results would not be considered statisti-
cally significant if Bonferroni’s adjustment to the 
α level (P < 0.05/3 = P < 0.017) was applied to 
account for possible experiment-wise error in 
analyzing related body composition submass 
measurements. Therefore, the minor changes ob-
served in body composition variables were not 
considered statistically significant. 
 
 
 
 
Figure 1.!Changes in TBM, LM, FM, and BF for the pla-
cebo group (open bars) and the pyruvate group (solid 
bars). ∗ P < 0.05. † Difference of P < 0.10 to P > 0.05. 
Data are presented as mean ± standard deviation. BF: 
body fat; FM: fat mass; LM: lean mass; TBM: total body 
mass. 
 
 
 
Blood chemistry profiles 
No significant or clinically meaningful differ-
ences were observed between groups in fasting 
urea nitrogen, creatinine, ratio of urea nitrogen to 
creatinine, uric acid, glucose, electrolyte status, 
total protein, albumin, white blood cells, or types 
of lymphocytes. There was some evidence that 
muscle and liver enzymes after training and sup-
plementation were lower in the PYR group (crea-
tine kinase 11 ± 18% versus 10 ± 11%, P = 0.97; 
lactate dehydrogenase 4 ± 5% versus −9 ± 4%, P 
= 0.06; aspartate aminotransferase 16 ± 7% ver-
sus −1 ± 7%, P = 0.13; alanine aminotransferase 
23 ± 17% versus −21 ± 9%, P = 0.03; γ-glutamyl 
transaminase 10 ± 12 % versus −7 ± 6%, P = 
0.06). Table 3 presents blood lipid profiles for 
the PL and PYR groups. There was some evi-
dence that PYR supplementation during training 
cancelled some of the normally positive effects 
of exercise on blood lipid profiles (total choles-
terol 3 ± 12% versus −2 ± 15%, P = 0.38; high-
density lipoprotein 14 ± 21% versus −6 ± 13%, P 
= 0.01; ratio of total cholesterol to high-density 
lipoprotein cholesterol −8 ± 16% versus 4 ± 12%, 
P = 0.06; low-density lipoprotein 4 ± 25% versus 
−7 ± 17%, P = 0.25; very low-density lipoprotein 
−9 ± 28% versus 19 ± 59%, P = 0.17; triacyl-
glycerols −13 ± 23% versus 18 ± 60%, P = 0.13). 
Maximal exercise capacity 
Exercise training significantly increased maximal 
oxygen uptake and time to exhaustion by averag-
es of 10.1% and 14%, respectively. However, no 
significant differences were observed between 
groups in the increases in maximal oxygen up-
take, ventilatory anaerobic threshold, RER, heart 
rate, or time to exhaustion. 
Walk test 
Fig. 2 presents the changes observed from base-
line values in oxygen uptake and RER. No sig-
nificant differences were observed in mean oxy-
gen uptake values to perform the walk (day 0: PL 
1.87 ± 0.26 L/min, PYR 1.71 ± 0.19 L/min; day 
30: PL 1.63 ± 0.25 L/min, PYR 1.64 ± 0.20 
L/min; P = 0.37 for group, P = 0.003 for time, P  
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= 0.08 for group × time). However, there was 
some evidence that mean RER values tended to 
increase after supplementation in the PYR group 
(day 0: PL 0.855 ± 0.04, PYR 0.841 ± 0.04; day 
30: PL 0.837 ± 0.03, PYR 0.855 ± 0.03, P = 
0.10). Interestingly, the trend toward higher RER 
values after PYR supplementation (PL −0.018 ± 
0.04, PYR 0.05 ± 0.05, P = 0.10 for group × time) 
occurred despite a slight decrease in mean oxy-
gen uptake values to perform the walk (PL −0.24 
± 0.27, PYR −0.07 ± 0.14, P = 0.08 for group × 
time). These findings suggest that the subjects 
may have developed a slightly higher rate of car-
bohydrate oxidation during exercise after PYR 
supplementation. No significant differences were 
observed in concentrations of glycerol, free fatty 
acid, and β-hydroxybutyrate between groups. 
DISCUSSION 
The purpose of this study was to determine 
whether calcium pyruvate supplementation sig-
nificantly affects body composition, metabolic  
 
 
Figure 2.!Changes in oxygen uptake and respiratory ex-
change ratio responses from baseline values observed dur-
ing the walk test for the placebo group (squares) and py-
ruvate group (diamonds). Data are presented as mean ± 
standard deviation. 
 
 
responses to exercise, or substrate utilization dur-
ing aerobic exercise in mildly overweight women 
who engage in a basic exercise program. The ra-
tionale for this study was based on previous find-
ings that indicated that pyruvate supplementation 
taken in dosages of up to 44 g/d enhances weight 
and fat loss among morbidly obese subjects (1), 
(2) and (13), shifts the resting substrate utiliza-
tion in favor of an increased proportion of energy 
derived from fats (1), and elicits a carbohydrate-
sparing effect in athletes, thus enabling them to 
improve exercise performance (3) and (4). 
Although some statistical trends were ob-
served, the present results indicated that PYR 
supplementation (10 g/d for 30 d) does not sig-
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nificantly affect overall changes in body compo-
sition during training. The trends observed were 
relatively minor and appear to have been influ-
enced to a greater degree to an unexplained in-
crease in body mass and fat mass observed in the 
PL group rather than to changes observed in the 
PYR group. In addition, changes in body compo-
sition values were within the typical test-to-test 
reliability of hydrostatic weighing (i.e., 5% to 
8%) and therefore may have simply been a result 
of standard assessment error. The present find-
ings are in contrast to previous studies that re-
ported that obese subjects who received large 
doses of pyruvate (e.g., 16 to 30 g/d) lost 0.8 to 
1.3 kg more fat than did the PL group, with no 
significant decreases in lean body mass (1), (2), 
(14) and (15). Moreover, because of the relative-
ly high cost of calcium pyruvate, one must ques-
tion whether the minor effects observed on fat 
loss (i.e., −0.4 ± 0.5 kg of fat mass) would be 
worth the costs associated with taking 10 g/d of 
calcium pyruvate. 
Although the mechanisms by which pyruvate 
might promote weight and fat loss are unknown, 
researchers have postulated that it may alter the 
manner and efficiency in which ingested foods 
are used, resulting in enhanced lipolysis and an 
increased proportion of energy derived from fats 
(1). Stanko et al. proposed that pyruvate supple-
mentation activates a futile cycle, such as the py-
ruvate-phosphoenolpyruvate cycle, resulting in 
excess energy and lipid expenditure (1). A futile 
cycle is produced when a non-equilibrium reac-
tion in the forward direction of a pathway is op-
posed by another unequal reaction in the reverse 
direction. Because a substrate is continuously 
converted and reconverted back to its original 
form, chemical energy is created and converted 
into heat, which is lost in the environment (8). 
This theory suggests that exogenously provided 
pyruvate may exceed the amount in which the 
cells could convert into acetyl coenzyme A. As a 
result, supplemental pyruvate may be trans-
formed into oxaloacetate within the Krebs cycle 
and then converted back to phosphoenolpyruvate, 
the precursor of pyruvate. Through such a futile 
cycle, excess energy could theoretically be ex-
pended, thereby promoting fat loss. 
In the present study, there was no evidence 
that the fat loss was attributed to an increase in 
fat metabolism. Serum concentrations of free fat-
ty acids and glycerol, which are indicative of 
mobilization and breakdown of triacylglycerols, 
did not differ significantly between the PYR and 
PL groups. Fewer non-esterified fatty acids were 
mobilized in response to PYR supplementation, 
suggesting less fat mobilization and/or metabo-
lism. Further, concentrations of β-
hydroxybutyrate, which is a ketone indicative of 
fat metabolism, did not statistically differ be-
tween trials or groups. Although the etiology of 
these observations remains to be determined, the 
exogenous pyruvate could simply have served as 
a carbohydrate fuel source during exercise, 
thereby decreasing the need to mobilize fat as a 
fuel. In support of this contention, previous stud-
ies have indicated that pyruvate enabled subjects 
to prolong their exercise times by enhancing 
fractional glucose extraction during rest and ex-
ercise that resulted in the provision of additional 
energy substrates (3), (4) and (16). Although this 
measurement was not assessed in the present in-
vestigation, RER values tended to be higher dur-
ing the walk test in the PYR group (P = 0.10) 
despite a slightly lower oxygen uptake, suggest-
ing greater carbohydrate oxidation. These find-
ings may suggest that the pyruvate can serve as 
an exogenous source of carbohydrate during ex-
ercise, which may increase carbohydrate oxida-
tion and energy expenditure. However additional 
research is necessary to evaluate the effects of 
PYR supplementation on substrate utilization 
during exercise. 
Interestingly, subjects who used PYR devel-
oped an increase in fasting serum levels of tri-
acylglycerol and very low-density lipoprotein, 
whereas levels of high-density lipoprotein cho-
lesterol were significantly decreased. In this re-
gard, fasting serum triacylglycerol levels were 14% 
higher after PYR supplementation, in contrast to 
a 14% lower value after training in the PL group. 
This pattern was also observed after the subjects 
performed the walk test after supplementation. 
These results contradict previous findings sug-
gesting that pyruvate supplementation (36 to 53 g) 
decreases total cholesterol and low-density lipo-
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protein concentrations by 4% and 5%, respec-
tively, in obese hyperlipidemic patients (17). 
Further, they are in agreement with findings of 
Ivy et al. (18) who reported that pyruvyl-glycine 
supplementation increased plasma triacylglycer-
ols in obese Zucker rats. Ivy et al. (18) hypothe-
sized that the increase in triacylglycerols was be 
due to a greater mobilization or decreased clear-
ance of blood lipids in response to consuming the 
pyruvyl-glycine diet. Although pre-exercise feed-
ing of calcium pyruvate may have only temporar-
ily increased blood lipids, additional research 
should evaluate this potentially negative side ef-
fect of PYR supplementation. 
The present results indicated that PYR sup-
plementation does not significantly affect maxi-
mal exercise capacity, ventilatory anaerobic 
threshold, or time to exhaustion. These findings 
indicated that PYR supplementation during train-
ing does not appear to be an effective ergogenic 
aid in women who initiate training. 
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